Cappato, Riccardo <br/><br/>
Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation.  [electronic resource] 

 -  European heart journal  Jul 2015 
 - 1805-11 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1522-9645 
<br/><br/><label>Standard No.: </label>10.1093/eurheartj/ehv177  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Arrhythmia Agents--therapeutic use<br/>Atrial Fibrillation--surgery<br/>Blood Loss, Surgical--prevention & control<br/>Catheter Ablation--adverse effects<br/>Drug Administration Schedule<br/>Factor Xa Inhibitors--administration & dosage<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Operative Time<br/>Prospective Studies<br/>Pulmonary Veins--surgery<br/>Recurrence<br/>Reoperation<br/>Rivaroxaban--administration & dosage<br/>Single-Blind Method<br/>Treatment Outcome<br/>Vitamin K--antagonists & inhibitors